Lin and others (2005; 2011) performed immunohistochemical analyses of CCN2 expression in primary CRC, and found that high CCN2 levels were associated with a decreased risk of peritoneal metastasis and with significantly higher disease-free and overall survival. This evidence concerns the gene CCN2 and colorectal carcinoma.